Novo Nordisk's pricing strategies from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of rate gouging, stating the stark contrast among U.S. prices and those in Europe and copyright. Comprehending the generation expenditures is essenti